BioSpace News Archive

Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that its 2018 Annual Report together with the Notice of Annual General Meeting and the Form of Proxy have been posted to shareholders.

Leading hearing protection company kicks off 2019 with strong review by trusted voices at Tiny Desk.

The American Diabetes Association strongly supports the re-introduction of legislation to expand access to Diabetes Self-Management Training for Medicare beneficiaries.

PACIFIC’s campaign for San Diego Blood Bank wins gold at American Advertising Awards

Arix Bioscience plc (LSE: ARIX), a global healthcare and life science company supporting medical innovation, will announce its annual results for the period ended 31 December 2018 on Thursday, 28 March 2019.

With More Activities Than Any Previous Nintendo Labo Kit, Kids and Families Can Make, Play, Discover and Even Create Their Own VR Games

This weekend Madrid will host the 3rd edition of the world congress “Soft Tissue Sarcoma: Evidence and Experience”, where oncologists and medical specialists from all over the world will meet to share the latest advances in the treatment and diagnosis of this disease, which accounts for less than 1% of adult cancers.

AB2 Bio Ltd, a Swiss advanced clinical-stage biotech company, specialized in developing innovative therapies for the treatment of severe systemic autoinflammatory diseases, announced today that a single-arm open label design with a randomized withdrawal phase for its ongoing pivotal Phase 3 trial under an Investigational New Drug (IND) Application for its product candidate Tadekinig alfa, has been accepted by the U.S. Food and Drug Administration (FDA).

Oxford Immunotec Global PLC (Nasdaq:OXFD) (the “Company”), a global, high-growth diagnostics company, today announced that Richard Altieri, the Company’s Chief Financial Officer (CFO), will retire on April 30, 2019.

HealthMyne Inc., a company focused on delivering quantitative imaging decision support for radiology and oncology, was recently selected by FirstHealth of the Carolinas to advance multiple oncology-related programs, including lung cancer screening and tumor conferences.